Exact Sciences Corp (MEX:EXAS)
MXN 872 0 (0%) Market Cap: 217.13 Bil Enterprise Value: 252.21 Bil PE Ratio: 0 PB Ratio: 3.40 GF Score: 80/100

Exact Sciences Corp at Jefferies Healthcare Conference (Virtual) Transcript

Jun 02, 2021 / 02:00PM GMT
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

All right. Good morning. Thanks for joining us. Welcome to the Jefferies 2021 Virtual Global Healthcare Conference. I'm Brandon Couillard. I cover the life science tools and diagnostics sector here at the firm. It is my great pleasure to have Exact Sciences with us back at the conference again this year.

Joining us for this fireside conversation, CEO, Kevin Conroy; as well as CFO and recently appointed COO, Jeff Elliott. Thank you both for being here. We'll just jump right into it.

Questions & Answers

Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Kevin, I'd like to start with the Cologuard business. Yes, I was certainly one that was expecting a faster recovery in the first quarter for that franchise. You did return to positive year-over-year revenue growth in the fourth quarter. The first quarter was down sequentially, again, mostly due to seasonality. But what are some of the gating factors that are still holding back Cologuard in terms of a faster

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot